India Antimalarial Drugs Market: Trends, Competition, and Opportunity Analysis from 2018 to 2028Posted by Kumar on October 20th, 2023 Introduction The India Antimalarial Drugs Market is poised for steady growth within the forecast period of 2024-2028, according to a report by TechSci Research titled "India Antimalarial Drugs Market – Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028." This anticipated growth can be attributed to several key factors that make India a significant player in the global fight against malaria. Factors Driving Growth High Prevalence of Malaria: One of the primary drivers of the India Antimalarial Drugs Market is the nation's high prevalence of malaria. The persistent burden of this disease necessitates a constant demand for effective treatment options. Rising Healthcare Expenditure: India's increasing healthcare expenditure is a crucial factor contributing to the growth of the antimalarial drugs market. With a growing emphasis on public health and access to healthcare, there is a rising commitment to combat malaria. Increasing Research and Development (R&D) Activities: The growth of the market is further fueled by the surge in R&D activities related to antimalarial drugs. Ongoing research initiatives are aimed at discovering innovative treatments and prophylactics to combat this deadly disease.
Who Will Benefit from This Report
Market Dynamics Drivers:
Challenges:
Impact of COVID-19 The COVID-19 pandemic has had a substantial impact on the India Antimalarial Drugs Market. While the demand for antimalarial drugs has remained steady, disruptions in supply chains and manufacturing have resulted in shortages of certain medications. Efforts to control COVID-19 have diverted resources and attention away from malaria control, potentially leading to an increase in malaria cases. This shift in focus has also impacted clinical trials and research related to new antimalarial treatments. However, the pandemic has raised awareness about public health measures and access to healthcare, which may ultimately benefit the fight against malaria in the long term. Market Segmentation The India Antimalarial Drugs Market is comprehensively segmented, allowing for in-depth analysis: Drug Class:
Drug Class Dominance: Artemisinin compounds are poised to dominate the market due to their proven effectiveness against malaria and the increasing prevalence of drug-resistant strains. These compounds, derived from the Artemisia annua plant, possess high potency against malaria parasites and can rapidly reduce parasite loads in patients. The Indian government's recent initiatives to increase the production and availability of artemisinin-based combination therapies (ACTs) will further solidify their market dominance. Distribution Channel:
Distribution Channel Dominance: Hospital pharmacies are expected to lead the market due to their role as primary sources of healthcare for many patients. These facilities often have the necessary resources and personnel to manage complex malaria cases and provide timely treatment. However, the rise of online pharmacies in India is anticipated to disrupt this trend. Online pharmacies offer convenience and accessibility, particularly in remote areas, and the COVID-19 pandemic has accelerated their adoption. As a result, online pharmacies are projected to capture the largest market share in the forecast period. The India Antimalarial Drugs Market presents a steady growth trajectory within the forecast period. Factors such as the high prevalence of malaria, increased healthcare expenditure, and burgeoning R&D activities drive this growth. While challenges such as drug-resistant strains and regional disparities exist, the fight against malaria remains a priority. The impact of COVID-19 has brought public health into focus, further strengthening the resolve to combat malaria. Stakeholders across various sectors, including pharmaceutical companies, healthcare providers, government, and investors, can capitalize on the opportunities and insights offered by this dynamic market. The dominance of artemisinin compounds and the evolution of distribution channels underscore the potential for innovative solutions in the battle against malaria in India.
Major companies operating in India Antimalarial Drugs Market are:
Customers can also request 10% free customization in this report. “The antimalarial drugs market in India is expected to grow steadily in the coming years, driven by factors such as the increasing prevalence of malaria, rising healthcare expenditure, and ongoing government initiatives. Clinical trials and research into new antimalarial drugs and therapies are also contributing to the market's growth. Technological advancements, such as the development of rapid diagnostic tests and the use of mobile health technologies to track and monitor disease outbreaks, are also expected to play a role in improving malaria control and treatment in India. However, challenges such as drug resistance and access to healthcare in certain regions remain significant obstacles to progress in this area. Continued investment in research and development, as well as efforts to improve access to healthcare, will be critical to ensuring continued growth and progress in the fight against malaria in India.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “India Antimalarial Drugs Market By Drug Class (Aryl aminoalcohol compounds, Antifolate compounds, Artemisinin compounds, Others), By Mechanism of Action (Treatment for Malaria, Prevention from Malaria), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Region, Competition, Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of India Antimalarial Drugs Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Antimalarial Drugs Market. Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=14998
Recently Published Reports – India Antimalarial Drugs Market United States Blood Glucose Monitoring Devices Market United States Food Amino Acids Market Contact Techsci Research- US - Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Germany – S-01, 2.floor, Subbelrather Straße, 15a Cologne, Germany 50823 Tel: +49 221 65058833
Like it? Share it! More by this author |